Colgrove John sold $22.7M of P (indirect holdings)

Colgrove John (Chief Visionary Officer) sold 200,000 indirectly-held shares of Everpure, Inc. (P) at an average of $113.26 ($110.15–$117.54, $22.65M total) across 5 trades over 2026-09-22 to 2026-09-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Colgrove John
Published Sep 24, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$P
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The large insider sell may pressure the stock if publicly listed, but the company appears private, limiting market impact.

02

Market read

Primary disclosure of a sizable insider sale; relevance mainly to investors tracking insider activity.

03

What to watch

Potential upcoming strategic shift or acquisition not disclosed.

Relevance 6/10Novelty 7/10Timing: filed 2026-09-24

Background

SEC Form 4 filing discloses a $22.7M open‑market sale by the Chief Visionary Officer of Everpure, Inc.

Market effects

Insider sell may signal concerns for water‑filtration sector but limited impact.

No immediate regional effect; Everpure is a niche player.

Minimal global relevance given private status.

Counterpoint

Sale could be a portfolio rebalancing rather than loss of confidence.

Key entities

  • Everpure, Inc.

    Water‑filtration company; issuer of the Form 4.

  • Colgrove John

    Chief Visionary Officer who sold 200,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.

$PMed

Needham raises Everpure stock price target on strong FY28 outlook

Needham raised its price target for Everpure (NYSE:P) to $150 from $140, maintaining a Buy rating. The firm cited Everpure's strong fiscal 2028 outlook, with projected revenue growth of 39% to 45% and operating margins of 24% to 26%. The company also reported second-quarter fiscal 2027 revenue of $1.186 billion, up 38% year-over-year. Several analysts have revised earnings upwards, and the stock has returned 68.3% over the last six months.